205 related articles for article (PubMed ID: 27096320)
21. Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130.
Howlett M; Judd LM; Jenkins B; La Gruta NL; Grail D; Ernst M; Giraud AS
Gastroenterology; 2005 Sep; 129(3):1005-18. PubMed ID: 16143138
[TBL] [Abstract][Full Text] [Related]
22. IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation.
Garaud S; Le Dantec C; Jousse-Joulin S; Hanrotel-Saliou C; Saraux A; Mageed RA; Youinou P; Renaudineau Y
J Immunol; 2009 May; 182(9):5623-32. PubMed ID: 19380809
[TBL] [Abstract][Full Text] [Related]
23. Celecoxib inhibits interleukin-6/interleukin-6 receptor-induced JAK2/STAT3 phosphorylation in human hepatocellular carcinoma cells.
Liu Y; Liu A; Li H; Li C; Lin J
Cancer Prev Res (Phila); 2011 Aug; 4(8):1296-305. PubMed ID: 21490132
[TBL] [Abstract][Full Text] [Related]
24. IL-6 induces MUC4 expression through gp130/STAT3 pathway in gastric cancer cell lines.
Mejías-Luque R; Peiró S; Vincent A; Van Seuningen I; de Bolós C
Biochim Biophys Acta; 2008 Oct; 1783(10):1728-36. PubMed ID: 18573283
[TBL] [Abstract][Full Text] [Related]
25. The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury.
Klein C; Wüstefeld T; Assmus U; Roskams T; Rose-John S; Müller M; Manns MP; Ernst M; Trautwein C
J Clin Invest; 2005 Apr; 115(4):860-9. PubMed ID: 15761498
[TBL] [Abstract][Full Text] [Related]
26. Cytokine signalling via gp130 in gastric cancer.
Howlett M; Menheniott TR; Judd LM; Giraud AS
Biochim Biophys Acta; 2009 Nov; 1793(11):1623-33. PubMed ID: 19665497
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-6 trans-signalling induces vascular endothelial growth factor synthesis partly via Janus kinases-STAT3 pathway in human mesothelial cells.
Yang X; Lin A; Jiang N; Yan H; Ni Z; Qian J; Fang W
Nephrology (Carlton); 2017 Feb; 22(2):150-158. PubMed ID: 26869278
[TBL] [Abstract][Full Text] [Related]
28. Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase.
Giordano V; De Falco G; Chiari R; Quinto I; Pelicci PG; Bartholomew L; Delmastro P; Gadina M; Scala G
J Immunol; 1997 May; 158(9):4097-103. PubMed ID: 9126968
[TBL] [Abstract][Full Text] [Related]
29. STAT3 Impairs STAT5 Activation in the Development of IL-9-Secreting T Cells.
Olson MR; Verdan FF; Hufford MM; Dent AL; Kaplan MH
J Immunol; 2016 Apr; 196(8):3297-304. PubMed ID: 26976954
[TBL] [Abstract][Full Text] [Related]
30. Higher proliferation of peritumoral endothelial cells to IL-6/sIL-6R than tumoral endothelial cells in hepatocellular carcinoma.
Zhuang PY; Wang JD; Tang ZH; Zhou XP; Quan ZW; Liu YB; Shen J
BMC Cancer; 2015 Nov; 15():830. PubMed ID: 26525581
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction.
Ogura H; Murakami M; Okuyama Y; Tsuruoka M; Kitabayashi C; Kanamoto M; Nishihara M; Iwakura Y; Hirano T
Immunity; 2008 Oct; 29(4):628-36. PubMed ID: 18848474
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1.
Loeffler S; Fayard B; Weis J; Weissenberger J
Int J Cancer; 2005 Jun; 115(2):202-13. PubMed ID: 15688401
[TBL] [Abstract][Full Text] [Related]
33. Activated Rac1 requires gp130 for Stat3 activation, cell proliferation and migration.
Arulanandam R; Geletu M; Feracci H; Raptis L
Exp Cell Res; 2010 Mar; 316(5):875-86. PubMed ID: 19852956
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-6 signal transduction and lymphocyte function.
Horn F; Henze C; Heidrich K
Immunobiology; 2000 Aug; 202(2):151-67. PubMed ID: 10993289
[TBL] [Abstract][Full Text] [Related]
35. cAMP/PKA enhances interleukin-1β-induced interleukin-6 synthesis through STAT3 in glial cells.
Tanabe K; Kozawa O; Iida H
Cell Signal; 2016 Jan; 28(1):19-24. PubMed ID: 26527061
[TBL] [Abstract][Full Text] [Related]
36. IL-6 mediated activation of STAT3 bypasses Janus kinases in terminally differentiated B lineage cells.
Kopantzev Y; Heller M; Swaminathan N; Rudikoff S
Oncogene; 2002 Oct; 21(44):6791-800. PubMed ID: 12360405
[TBL] [Abstract][Full Text] [Related]
37. IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway.
Wang L; Yi T; Kortylewski M; Pardoll DM; Zeng D; Yu H
J Exp Med; 2009 Jul; 206(7):1457-64. PubMed ID: 19564351
[TBL] [Abstract][Full Text] [Related]
38. Inflammation and cancer: IL-6 and STAT3 complete the link.
Bromberg J; Wang TC
Cancer Cell; 2009 Feb; 15(2):79-80. PubMed ID: 19185839
[TBL] [Abstract][Full Text] [Related]
39. B cells promote tumor progression via STAT3 regulated-angiogenesis.
Yang C; Lee H; Pal S; Jove V; Deng J; Zhang W; Hoon DS; Wakabayashi M; Forman S; Yu H
PLoS One; 2013; 8(5):e64159. PubMed ID: 23734190
[TBL] [Abstract][Full Text] [Related]
40. CD5 expression promotes multiple intracellular signaling pathways in B lymphocyte.
Mageed RA; Garaud S; Taher TE; Parikh K; Pers JO; Jamin C; Renaudineau Y; Youinou P
Autoimmun Rev; 2012 Sep; 11(11):795-8. PubMed ID: 22349614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
